Ajanta Pharma Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| EBITDA | 1,024 | 1,044 | 0 |
| EBIT | 908 | 919 | 0 |
| Earning Per Share | 75 | 82 | 46 |
| Expenses | 1,891 | 2,412 | 2,959 |
| Net Profit | 654 | 713 | 588 |
| Net Profit Margin | 23 | 21 | 16 |
| Operating Profit Margin | 35 | 31 | 24 |
| Profit Before Tax | 900 | 909 | 745 |
| Dividends Per Share | 10 | 10 | 0 |
| Operation Revenue | 2,916 | 3,457 | 3,841 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 | |
| 2023 | 0 | 0 | 2,835.49 | NA | 4,038.35 | |
| 2023 | 0 | 0 | 372.90 | NA | 385.50 | |
| 2023 | 0 | 0 | 103.87 | NA | 140.39 | |
| 2022 | 1,257.60 | 2,182.90 | 978.50 | 7,628.10 | 1,190 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2011 | 2011 | 2011 | 2011 | 2021 | |
|---|---|---|---|---|---|
| Operating Activities | 95 | 95 | 95 | 95 | 576 |
| Investing Activities | -51 | -51 | -51 | -51 | -282 |
| Financing Activities | -56 | -56 | -56 | -56 | -318 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -11 | -11 | -11 | -11 | -24 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2023 | 4,959.33 | -7,943.68 | 2,376.07 | -608.28 | |
| 2022 | 3,325.90 | -1,871.88 | -1,599.79 | -145.77 | |
| 2023 | 723.95 | -447.59 | -261.96 | 14.40 | |
| 2020 | 140.90 | -44.50 | -38.55 | 57.85 | |
| 2017 | 640 | -498.50 | -177.50 | -36 |
Financials
All values are in Rs Cr